SCRS Eagle Award
About The Award
For more than a decade, the SCRS Eagle Award has recognized outstanding leadership, professionalism, integrity, passion, and dedication to advancing clinical research through strong site partnerships.
The symbiotic relationship between sites and the industry stands as a cornerstone for the success of clinical research, influencing innovation and advancement within the field. It is the synergy between these organizations that cultivates invaluable experiences and insights for the most crucial member of our work — the patient.
The SCRS Eagle Award is a tribute to exceptional partnerships forged between sites and the CROs and sponsors they work with every day.
Congratulations to the 2024 Eagle Award Recipients
Sponsor Recipient
CRO Recipient
Dear Site Partners,
We are deeply honored to be the recipient of the Society for Clinical Research Sites (SCRS) Eagle Sponsor of Choice Award for the third year in a row. This award celebrates great partnerships between sites and the sponsors they work with every day across the globe.
Clinical research is a collaborative effort and one that can only be achieved with dedicated sites and staff that continuously strive for excellence. This teamwork allows us to achieve our societal goals, bringing new therapies and hope to patients around the world. Together, we ensure that “No Patient Is Left Behind.”
So, thank you to all the patients, sites, staff, IRBs, partners, nurses, CRAs and so many others who diligently work to meet our collective goals.
Thank you for your partnership!
Andy Lee
Senior Vice President & Head, Global Clinical Trial Operations, Merck
Dear Site Partners:
We are extremely humbled and honored to receive the Society for Clinical Research Sites’ (SCRS) Eagle Award for the second consecutive year. This award is a testament to our deep commitment to sites and a celebration of the collaborative spirit between our organizations.
Sites play a crucial role in our shared mission to bring innovative medicines to patients around the world. We appreciate your insights that help us be stronger partners for you – alleviating clinical trial burdens and enhancing the overall experience for sites and patients alike.
Thank you for your trust in Parexel and your continued partnership. We look forward to many more successful years of working together to advance global healthcare.
Sincerely,
Deb Tatton President, Global Clinical and Data Operations, Parexel
Teri Karcher EVP, Head of Launch Excellence & Chief Drug Development Officer, Parexel
Preceding Recipients
For more than a decade, the Eagle Awards have provided important awareness of the value of communication and trust in the site-industry partnership.
Sponsor
2013 – Novartis
2014 – Eli Lilly
2015 – MSD
2016 – Novo Nordisk
2017 – Eli Lilly
2018 – AstraZeneca
2019 – Pfizer
2020 – Pfizer
2021 – Pfizer
2022 – MSD
2023 – MSD
CRO
2013 – Quintiles
2014 – Quintiles
2015 – Quintiles
2016 – Quintiles
2017 – INC Research/InVentive
2018 – Syneos Health
2019 – Syneos Health
2020 – Syneos Health
2021 – PPD
2022 – PPD
2023 – Parexel